SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark's diabetes drug to enter phase lll trials

25 Jun 2009 Evaluate

Glenmark's novel molecule for diabetes- Melogliptin will now enter phase III trials. The phase II B trials have been successfully completed with the molecule achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight.

 

Global phase III trials have been planned with melogliptin and are due to start at the end of 2009 following regulatory approvals. These studies are designed to evaluate the compound both as monotherapy and in combination with other anti-diabetic therapies in patients with type 2 diabtes mellitus.

 

Glenmark continues to be in discussions with various licensing partners to take the molecule forward. The global diabetes markets is estimated at $24 bn in 2007 and projected to grow to $45 bn by 2018. It will likely be the leading drug class in metabolic and cardio vascular market. Oral anti-diabetics will drive the market growth with a projected share of 70 per cent of the total market.

crackcrack

Glenmark Pharma Share Price

2233.40 3.75 (0.17%)
21-Apr-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.20
Dr. Reddys Lab 1220.40
Cipla 1233.30
Zydus Lifesciences 930.70
Lupin 2314.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×